Moderna, Inc. (NASDAQ:MRNA) | WebDisclosure

Basculer en Français

8315	Companies
115945	Keywords
55974	Articles
62839	Press releases

Home
Companies
Moderna, Inc.

BRIEF

published on 03/27/2024 at 11:35, 7 months 30 days ago

Moderna annonce des avancées significatives dans ses programmes de développement de vaccins

Technologie ARNm Développement De Vaccins Moderne Essais Cliniques De Phase 3 COVID 19
PRESS RELEASE

published on 03/27/2024 at 11:30, 7 months 30 days ago

Moderna Advances Multiple Vaccine Programs to Late-Stage Clinical Trials
Moderna announces successful clinical readouts for fourth respiratory vaccine candidate meeting Phase 3 endpoints and provides updates on vaccine portfolios, clinical trials, and financial agreements at fifth Vaccines Day event

Clinical Trials Moderna Vaccine Phase 3 Respiratory
BRIEF

published on 03/26/2024 at 12:05, 8 months ago

Moderna Reports Positive Results in Phase 3 Trial of New COVID-19 Vaccine

Public Health COVID-19 Vaccine Moderna Phase 3 Trial MRNA-1283
BRIEF

published on 03/26/2024 at 12:05, 8 months ago

Moderna annonce des résultats positifs dans l’essai de phase 3 d’un nouveau vaccin contre la COVID-19

Moderne ARNm-1283 Vaccin Contre Le Covid-19 Essai De Phase 3 Santé Publique
PRESS RELEASE

published on 03/26/2024 at 12:00, 8 months ago

Moderna Achieves Positive Interim Results from Phase 3 Trial of Next-Generation COVID-19 Vaccine
Moderna's mRNA-1283 shows higher immune response than mRNA-1273.222 in Phase 3 trial. Next-generation vaccine offers longer shelf life and storage benefits, paving way for flu-COVID combo vaccine, mRNA-1083

COVID-19 Vaccine Moderna Phase 3 Trial MRNA-1283 MRNA-1273.222
BRIEF

published on 02/29/2024 at 13:00, 8 months 26 days ago

Moderna annonce son cinquième événement annuel pour les investisseurs axé sur les vaccins

Investisseurs Webdiffusion Moderna Evénement Investisseurs Vaccins À ARNm
BRIEF

published on 02/29/2024 at 13:00, 8 months 26 days ago

Moderna Announces Fifth Annual Vaccine-Focused Investor Event

Investors Webcast Moderna Investor Event MRNA Vaccines
PRESS RELEASE

published on 02/29/2024 at 13:00, 8 months 26 days ago

Moderna to Host Fifth Annual Investor Event For Vaccines and Business Updates on March 27, 2024
Moderna, Inc. announces its fifth annual Investor Event focusing on vaccines and business updates on March 27, 2024. Presentation at 9:00 a.m. ET. Live webcast available on the Moderna website

Webcast MRNA Medicine Moderna Investor Event MRNA Vaccines
BRIEF

published on 02/28/2024 at 13:00, 8 months 27 days ago

Moderna annonce sa participation à des conférences d'investisseurs

Webcast Moderna Santé Conférences D'investisseurs Technologie ARNm
BRIEF

published on 02/28/2024 at 13:00, 8 months 27 days ago

Moderna announces participation in investor conferences

Investor Conferences Webcast MRNA Technology Moderna Health

Accesswire

Published on 11/26/2024 at 13:00, 25 minutes ago

Eagle Plains Reports up to 76.30 g/t Gold at Snowstorm Project and Significantly Increases Land Package
Published on 11/26/2024 at 13:00, 25 minutes ago

Toggle.ai Integrates FOTOgpt.ai Studio into Map Dynamics, Enhancing AI Photography Capabilities for over 400 Enterprise Clients
Published on 11/26/2024 at 13:00, 25 minutes ago

ARway.ai Integrates Toggle’s FOTOgpt.ai Studio into Map Dynamics, Expanding AI Photography Capabilities for its Over 400 Enterprise Clients
Published on 11/26/2024 at 13:00, 25 minutes ago

Azarga Metals - Option Maintenance Payment in Shares
Published on 11/26/2024 at 13:00, 25 minutes ago

Quebec Precious Metals Reports Consistent +20 m Thick Spodumene-Bearing Pegmatite Up to 150 m Deep from Its Maiden Drilling Program on its 100%-owned Lithium Ninaaskumuwin Discovery, James Bay, Quebec

View all ACCESSWIRE

EQS Group

Published on 11/26/2024 at 12:47, 38 minutes ago

LR Health & Beauty SE further increases growth trend in the third quarter
Published on 11/26/2024 at 12:45, 40 minutes ago

EQS-Adhoc: LR Health & Beauty SE: Publication of figures for the third quarter of 2024 and adjustment of the forecast for the 2024 financial year
Published on 11/26/2024 at 12:30, 55 minutes ago

Form 8.3 - LOYS AG: Learning Technologies Group plc
Published on 11/26/2024 at 12:30, 55 minutes ago

Immunic, Inc. to Participate in Investor Conference in December
Published on 11/26/2024 at 12:17, 1 hour 7 minutes ago

EQS-Adhoc: Brenntag CEO Dr. Christian Kohlpaintner will not extend his contract beyond 2025

Les Echos

Published on 11/26/2024 at 08:30, 4 hours 55 minutes ago

Cie du Bois Sauvage: Terugkoop van eigen aandelen – Week van 18/11/2024 tot 22/11/2024
Published on 11/26/2024 at 08:30, 4 hours 55 minutes ago

Cie du Bois Sauvage : Rachat d’actions propres – semaine du 18/11/2024 au 22/11/2024
Published on 11/26/2024 at 08:30, 4 hours 55 minutes ago

Cie du Bois Sauvage: Buy back of own shares – week from 18/11/2024 to 22/11/2024
Published on 11/26/2024 at 07:57, 5 hours 28 minutes ago

Neoen and Equinix sign their first PPA in Italy supporting decarbonization of the local grid
Published on 11/26/2024 at 07:57, 5 hours 28 minutes ago

Neoen et Equinix signent leur premier PPA en Italie en faveur de la décarbonation du réseau électrique

View all LES ECHOS COMFI WIRE